Cargando…

Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis

Atherosclerotic vascular disease resulting from unstable plaques is the leading cause of morbidity and mortality in subjects with type 2 diabetes (T2D), and thus a major therapeutic goal is to discover T2D drugs that can also promote atherosclerotic plaque stability. Genetic or pharmacologic inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozcan, Lale, Kasikara, Canan, Yurdagul, Arif, Kuriakose, George, Hubbard, Brian, Serrano-Wu, Michael H., Tabas, Ira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118275/ https://www.ncbi.nlm.nih.gov/pubmed/33983975 http://dx.doi.org/10.1371/journal.pone.0246600

Ejemplares similares

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
por: Yurdagul, Arif, et al.
Publicado: (2018)

CaMKII in Cardiometabolic Disease
por: Ozcan, Lale, et al.
Publicado: (2014)

A New Activator of Hepatocyte CaMKII in Fasting and Type 2 Diabetes
por: Ozcan, Lale, et al.
Publicado: (2018)

NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis
por: Li, Gang, et al.
Publicado: (2010)

The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation
por: Wei, Yongjie, et al.
Publicado: (2015)

Metabolic Consequences of Efferocytosis and its Impact on Atherosclerosis
por: Yurdagul, Arif
Publicado: (2021)

MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression
por: Soni, Sourabh, et al.
Publicado: (2019)

Identification and Functional Analysis of MAPKAPK2 in Hyriopsis cumingii
por: Gu, Yang, et al.
Publicado: (2022)

Recent insights into the cellular biology of atherosclerosis
por: Tabas, Ira, et al.
Publicado: (2015)

Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity
por: Subramanian, Manikandan, et al.
Publicado: (2015)

Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability
por: Shen, Xinyi, et al.
Publicado: (2021)

Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis
por: Kumar, Dhananjay, et al.
Publicado: (2023)

A Novel Role for MAPKAPK2 in Morphogenesis during Zebrafish Development
por: Holloway, Beth A., et al.
Publicado: (2009)

Hypercoagulability Impairs Plaque Stability in Diabetes-Induced Atherosclerosis
por: Ambreen, Saira, et al.
Publicado: (2022)

MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability
por: Soni, Sourabh, et al.
Publicado: (2019)

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
por: Preusch, Michael R, et al.
Publicado: (2016)

Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis
por: Beldman, Thijs J., et al.
Publicado: (2017)

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
por: Chen, Wei, et al.
Publicado: (2021)

The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation
por: Moens, Ugo, et al.
Publicado: (2013)

Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
por: Funk, Steven Daniel, et al.
Publicado: (2012)

Macrophages Use Apoptotic Cell-Derived Methionine and DNMT3A During Efferocytosis to Promote Tissue Resolution
por: Ampomah, Patrick B., et al.
Publicado: (2022)

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
por: Herranz, Nicolás, et al.
Publicado: (2015)

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
por: Fredman, Gabrielle, et al.
Publicado: (2016)

Overexpression of STAMP2 suppresses atherosclerosis and stabilizes plaques in diabetic mice
por: Wang, Jia, et al.
Publicado: (2014)

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
por: Petri, Marcelo H., et al.
Publicado: (2015)

Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
por: Poels, Kikkie, et al.
Publicado: (2020)

The role of long noncoding RNA Nron in atherosclerosis development and plaque stability
por: Du, Meng, et al.
Publicado: (2022)

Consolidating the association of biallelic MAPKAPK5 pathogenic variants with a distinct syndromic neurodevelopmental disorder
por: Maroofian, Reza, et al.
Publicado: (2023)

The Relation between Atherosclerosis Plaque Composition and Plaque Rupture
por: Babaniamansour, Parto, et al.
Publicado: (2020)

Transgenic mice expressing constitutive active MAPKAPK5 display gender-dependent differences in exploration and activity
por: Gerits, Nancy, et al.
Publicado: (2007)

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
por: Zheng, Fei, et al.
Publicado: (2014)

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis
por: Poels, Kikkie, et al.
Publicado: (2020)

The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome
por: Davis, Terence, et al.
Publicado: (2013)

MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients
por: Zhong, Zhenggang, et al.
Publicado: (2023)

Revealing oxidative stress-related genes in osteoporosis and advanced structural biological study for novel natural material discovery regarding MAPKAPK2
por: Zhao, Yingjing, et al.
Publicado: (2022)

Plaque Rupture in Coronary Atherosclerosis Is Associated With Increased Plaque Structural Stress
por: Costopoulos, Charis, et al.
Publicado: (2017)

Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice
por: Donners, Marjo M. P. C., et al.
Publicado: (2012)

Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice
por: Sastre, Cristina, et al.
Publicado: (2014)

CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation
por: Chang, Ting-Ting, et al.
Publicado: (2020)

Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization
por: Chen, Yung-Chih, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lj75tjrga91npaiphhc79mm164